Couldn't agree more the right marketing, sales of Sofdra could be through the rood.
Another social media promotion on Threads and Instagram by Dr Waleed Alsalhi, about BOT's Sofdra, FDA New Treatment for Primary Axillary Hyperhidrosis, in Arabic. A great promotion for potential market targeting in the Middle Eastern Community/Countries.
Dr Waleed Alsalhi, Biography
* Consultant Dermatologist Department at Makkah University, KSA Hairs & Nails fellowship in Miami University, FL, USA.
* Triple board certified consultant dermatologist
* The Saudi & Arab Boards in Dermatology & Venereology
* European Board of dermatology & venereology
* Assistant Professor in Dermatology, Collage of Medicine, AI-Majmaah University
ps. unable to upload the pictures from Threads and Twitter to here, please search Dr Waleed Alsalhi o
BOT - Anything but charting, page-9088
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.020(6.25%) |
Mkt cap ! $617.9M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 34.3¢ | 32.5¢ | $1.814M | 5.424M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 489055 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 340303 | 4 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |